Clinical Utility and Factors Associated with Certolizumab Pegol Drug Levels and Anti-Drug Antibodies in the Long-Term Treatment of Rheumatoid Arthritis

Full text for this publication is not currently held within this repository. Alternative links are provided below where available.

Author(s): Jani M, Chinoy H, Isaacs J, Morgan AW, Wilson A, Hyrich KL, Plant D, Barton A

Publication type: Conference Proceedings (inc. Abstract)

Publication status: Published

Conference Name: 2015 ACR/ARHP Annual Meeting

Year of Conference: 2015

Pages: 2758

Print publication date: 01/10/2015

Online publication date: 29/09/2015

Acceptance date: 01/01/1900

ISSN: 2326-5191

Publisher: Wiley

URL: https://doi.org/10.1002/art.39448

DOI: 10.1002/art.39448

Series Title: Arthritis & Rheumatology

ePrints